Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma
Clinical trial NCT06138769 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06138769
- Sponsor
- Asan Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-20
- Primary completion
- 2026-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.